APA (7th ed.) Citation

B, B., Z, Z., Y, L., A, N., SS, T., M, E., . . . G, F. (2019). Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioral and myelin alterations rescuable by a remyelinating drug. Nature neuroscience, 22(5), 700. https://doi.org/10.1038/s41593-019-0380-9

Chicago Style (17th ed.) Citation

B, Barak, et al. "Neuronal Deletion of Gtf2i, Associated with Williams Syndrome, Causes Behavioral and Myelin Alterations Rescuable by a Remyelinating Drug." Nature Neuroscience 22, no. 5 (2019): 700. https://doi.org/10.1038/s41593-019-0380-9.

MLA (9th ed.) Citation

B, Barak, et al. "Neuronal Deletion of Gtf2i, Associated with Williams Syndrome, Causes Behavioral and Myelin Alterations Rescuable by a Remyelinating Drug." Nature Neuroscience, vol. 22, no. 5, 2019, p. 700, https://doi.org/10.1038/s41593-019-0380-9.